Summit Therapeutics
SMMT
SMMT
13 hedge funds and large institutions have $3.32M invested in Summit Therapeutics in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $6.54M → $3.32M (-$3.22M)
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21K | |
| 2 | +$12K | |
| 3 | +$11.9K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11.7K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$1K |
Top Sellers
| 1 | -$64K | |
| 2 | -$51K | |
| 3 | -$34K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$33K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$24K |